General-purpose AI assistant (health use)
Microsoft Copilot (consumer health)
This assessment covers the dedicated Copilot Health preview. Its documented Health-space protections, citations, and connection controls must be distinguished from general Copilot health conversations. Preview access and subscription conditions remain relevant.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 71 out of 100 toward patient-directed
Dedicated Copilot Health preview, with general Copilot health answers identified separately. Health-space protections must not be attributed to every health conversation in general Copilot.
Potentially agency-expanding, subscription-gated preview
This assessment covers the dedicated Copilot Health preview. Its documented Health-space protections, citations, and connection controls must be distinguished from general Copilot health conversations. Preview access and subscription conditions remain relevant.
Patient agency
How this tool changes agency
Citations and navigation support independent checking and action. Public evidence does not establish a patient workflow to correct generated insights or propagate corrections to source records.
Current in-account availability, connector retention and correction behavior were not tested
Patient agency assessment
Who sets and changes the goal?
Patients bring goals and questions, select connections and can disconnect them. The dedicated space provides meaningful direction, although recommendation and source-selection design remain vendor controlled.
What can the patient understand, question, or do?
Citations and navigation support independent checking and action. Public evidence does not establish a patient workflow to correct generated insights or propagate corrections to source records.
Can the patient evaluate the conditions of use?
Distinguishing the protected Health space from general Copilot is essential. Privacy and certification claims need their proper scope. Patient-organization input is evidence of consultation, not patient governance.
Text findings
Conditions of use
Published controls and their limits
Distinguishing the protected Health space from general Copilot is essential. Privacy and certification claims need their proper scope. Patient-organization input is evidence of consultation, not patient governance.
What remains unknown?
Not tested or not established
Current in-account availability, connector retention and correction behavior were not tested
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
- https://www.microsoft.com/en-us/microsoft-copilot/blog/2026/05/29/copilot-health-now-in-preview/
- https://microsoft.ai/news/introducing-copilot-health/
- https://www.microsoft.com/en-us/privacy/microsoft-consumer-health-data-privacy-policy
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Current in-account availability, connector retention and correction behavior were not tested No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Moderate for documented preview design (AI-assisted draft)